News Daily News Shock’s Added Risk in Acute MI Restricted to the First Few Months After Discharge Caitlin E. Cox February 16, 2016
News Industry News Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure August 31, 2015